U.S. Markets closed
  • S&P 500

    3,310.11
    +39.08 (+1.19%)
     
  • Dow 30

    26,659.11
    +139.16 (+0.52%)
     
  • Nasdaq

    11,185.59
    +180.72 (+1.64%)
     
  • Russell 2000

    1,561.58
    +18.30 (+1.19%)
     
  • Crude Oil

    36.15
    -0.02 (-0.06%)
     
  • Gold

    1,867.50
    -0.50 (-0.03%)
     
  • Silver

    23.36
    +0.00 (+0.02%)
     
  • EUR/USD

    1.1681
    -0.0069 (-0.5840%)
     
  • 10-Yr Bond

    0.8350
    +0.0540 (+6.91%)
     
  • Vix

    37.59
    -2.69 (-6.68%)
     
  • GBP/USD

    1.2934
    -0.0053 (-0.4087%)
     
  • USD/JPY

    104.5420
    +0.2410 (+0.2311%)
     
  • BTC-USD

    13,473.23
    -69.69 (-0.51%)
     
  • CMC Crypto 200

    264.05
    +21.37 (+8.80%)
     
  • FTSE 100

    5,581.75
    -1.05 (-0.02%)
     
  • Nikkei 225

    23,331.94
    -86.57 (-0.37%)
     

VIVO Cannabis™ to Present at the Virtual Gravitas Healthcare Investor Day

·1 min read

TORONTO, Sept. 29, 2020 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today announced that Barry Fishman, VIVO's CEO, will present an overview of the Company at the Gravitas Healthcare Investor Day on Thursday, October 1, 2020 at 2:30 p.m. ET.

Vivo Cannabis (CNW Group/VIVO Cannabis Inc.)
Vivo Cannabis (CNW Group/VIVO Cannabis Inc.)

This year's Gravitas Healthcare Investor Day will feature several leaders in healthcare and will be attended virtually by institutional and retail investors from North America and abroad. For additional details about the conference and Gravitas Securities Inc., please visit: www.gravitassecurities.com and you can register for the conference by clicking here.

About VIVO Cannabis™

VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms™, Beacon Medical™, Fireside™, Lumina™ and Canadian Bud Collection™. The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO's patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The Company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information visit: vivocannabis.com.

SOURCE VIVO Cannabis Inc.

Cision
Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2020/29/c0617.html